Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-85.94	35.68	253.74
Graham Fair Price	-40.78	12.10	20.42
PEG	-61.67	-1.11	-0.68
Price/Book	0.24	0.89	0.89
Price/Cash Flow	-62.54	152.38	-406.79
Prices/Earnings	173.22	71.93	26.33
Price/Sales	14.35	10.83	9.47
Price/FCF	-62.54	152.38	-406.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.15	0.48	0.44
Operating Margin	957.25	0.36	-0.03
ROA	-62.85	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-63.31
ROIC	< 0.005	-0.08	15804.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	-0.15	-93.19
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.17	10.29	779.61
EPS QOQ	-0.38	-0.65	-69.00
FCF QOQ	-1.10	3.68	233.26
Revenue QOQ	0.13	-0.12	-6.60
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.87	8.86	28.92
Days Sales Outstanding (DSO)	198.87	214.07	7.64
Inventory Turnover	13.09	10.15	-22.43
Debt/Capitalization	0.37	0.38	0.49
Quick Ratio	1.52	1.35	-11.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.77	45.73	-2.22
Cash	8.63	7.80	-9.56
Capex	-0.82	-0.31	61.74
Free Cash Flow	-0.10	0.27	161.66
Revenue	4.41	3.78	-14.29
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.76	1.57	-10.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	87.75	12.62	-85.62
Naive Interpretation	Member

06 - Financial Health · Weak

Rating